Zobrazeno 1 - 2
of 2
pro vyhledávání: '"Hoyub Yoon"'
Autor:
Young Wook Choi, In Ho Chang, Hoyub Yoon, Min Ji Cho, Young Mi Whang, Myeong Joo Kim, Tae-Hyoung Kim
Publikováno v:
Journal of Cellular Physiology. 234:13083-13096
Rapamycin, a mammalian target of rapamycin (mTOR) inhibitor, has significant potential for application in the treatment of urothelial carcinoma (URCa) of the bladder. Previous studies have shown that regulation of the AMP-activated serine/threonine p
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::fac857e660ec871c897911ccd3c43c38
https://doi.org/10.1002/jcp.27979
https://doi.org/10.1002/jcp.27979
Autor:
Gwang Yong Hwang, Young Wook Choi, Serk In Park, Young Mi Whang, In Ho Chang, Da Hyeon Yoon, Hoyub Yoon
Publikováno v:
Cancers
Volume 12
Issue 12
Cancers, Vol 12, Iss 3679, p 3679 (2020)
Volume 12
Issue 12
Cancers, Vol 12, Iss 3679, p 3679 (2020)
The Mycobacterium Bacillus Calmette-Gué
rin cell wall skeleton (BCG-CWS), the main immune active center of BCG, is a potent candidate non-infectious immunotherapeutic drug and an alternative to live BCG for use against urothelial carcinoma
rin cell wall skeleton (BCG-CWS), the main immune active center of BCG, is a potent candidate non-infectious immunotherapeutic drug and an alternative to live BCG for use against urothelial carcinoma
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e2fd943bb9c00a7b3d87439f8868d816